Article Information
History
- October 10, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Kevin A. Nuno1,2,3,4,13,
- Armon Azizi2,3,4,5,13,
- Thomas Köhnke2,3,4,
- Caleb A. Lareau6,7,
- Asiri Ediwirickrema1,2,3,4,
- M. Ryan Corces1,2,3,4,8,9,10,
- Ansuman T. Satpathy6,7,11,12 and
- Ravindra Majeti2,3,4,*
- 1Cancer Biology Graduate Program, Stanford University School of Medicine, Stanford, CA, USA
- 2Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA, USA
- 3Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA
- 4Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, CA, USA
- 5University of California Irvine School of Medicine, Irvine, California
- 6Department of Pathology, Stanford University, Stanford, CA, USA
- 7Program in Immunology, Stanford University, Stanford, CA, USA
- 8Gladstone Institute of Neurological Disease, San Francisco, California
- 9Gladstone Institute of Data Science and Biotechnology, San Francisco, California
- 10Department of Neurology, University of California San Francisco, San Francisco, California
- 11Parker Institute for Cancer Immunotherapy, Stanford University, Stanford, CA, USA
- 12Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA
- ↵*Corresponding Author: Ravi Majeti, 265 Campus Drive, G3021B Stanford, CA 94305-5461, 650.721.6376, rmajeti{at}stanford.edu
↵13 These authors contributed to this work equally
Posted October 10, 2023.
